LAT2 and acute myeloid leukemia: Using the previously published proteomic dataset of a well characterized AML cohort (28), we noticed that AML patients with an immunophenotypic profile characteristic for GMP-Like AML presented increased NTAL and its interactor protein levels when compared with AML samples with a more /HSC-like immunophenotype (Fig. 6D).